SCHEMBL1286786

SCHEMBL1286786

[O]NC(=O)CP(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphonoacetohydroxamate SCHEMBL411386 0.77
SCHEMBL7482527 0.74
SCHEMBL9257748 0.74
Lithium Ion SCHEMBL28856344 0.72 ENO1 (0.56)
SCHEMBL8446275 0.70 ENO1 (0.54)
SCHEMBL5063490 0.70 ENO1 (0.54)
SCHEMBL11663515 0.69 ENO1 (0.52)
Butane SCHEMBL11180943 0.69 ENO1 (0.52)
SCHEMBL9204263 0.69 ENO1 (0.52)
SCHEMBL21685551 0.69 ENO1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9642835-B2 Modulators of GTPase and use in relevant treatment STC.UNM (US) 2017-05-09 US disclosed
US-20130345277-A1 Modulators of GTPase and Use In Relevant Treatment Kansas University Center for Technology Commercialization, Inc. (US) 2013-12-26 US disclosed
US-20130281493-A1 Method for Treating Cancer Harboring a p53 Mutation THE TRUSTEES OF THE UNIVERSITY OF COLUMBIA IN THE CITY OF NEW YORK (US) 2013-10-24 US disclosed
EP-2625294-A2 METHOD FOR TREATING CANCER HARBORING A p53 MUTATION Columbia University (US) 2013-08-14 EP disclosed
WO-2012048303-A2 METHOD FOR TREATING CANCER HARBORING A p53 MUTATION COLUMBIA UNIVERSITY (US) 2012-04-12 WO disclosed